| Literature DB >> 29398561 |
Charlotte A James1, Krystle K Q Yu2, Martine Gilleron3, Jacques Prandi3, Vijayendar R Yedulla4, Zuzanna Z Moleda4, Eleonora Diamanti5, Momin Khan5, Varinder K Aggarwal5, Josephine F Reijneveld6, Peter Reinink6, Stefanie Lenz6, Ryan O Emerson7, Thomas J Scriba8, Michael N T Souter9, Dale I Godfrey9, Daniel G Pellicci9, D Branch Moody10, Adriaan J Minnaard4, Chetan Seshadri11, Ildiko Van Rhijn12.
Abstract
Mycobacterial cell wall lipids bind the conserved CD1 family of antigen-presenting molecules and activate T cells via their T cell receptors (TCRs). Sulfoglycolipids (SGLs) are uniquely synthesized by Mycobacterium tuberculosis, but tools to study SGL-specific T cells in humans are lacking. We designed a novel hybrid synthesis of a naturally occurring SGL, generated CD1b tetramers loaded with natural or synthetic SGL analogs, and studied the molecular requirements for TCR binding and T cell activation. Two T cell lines derived using natural SGLs are activated by synthetic analogs independently of lipid chain length and hydroxylation, but differentially by saturation status. By contrast, two T cell lines derived using an unsaturated SGL synthetic analog were not activated by the natural antigen. Our data provide a bioequivalence hierarchy of synthetic SGL analogs and SGL-loaded CD1b tetramers. These reagents can now be applied to large-scale translational studies investigating the diagnostic potential of SGL-specific T cell responses or SGL-based vaccines.Entities:
Keywords: CD1; T cell receptor; T cells; antigen-presentation; human; lipid antigen; mycobacteria; tuberculosis
Mesh:
Substances:
Year: 2018 PMID: 29398561 PMCID: PMC5910231 DOI: 10.1016/j.chembiol.2018.01.006
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116